Quick Answer
Quercetin Immune Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Chlorhexidine is the gold standard for plaque control, but it is associated with side effects on prolonged use.
Key Takeaways
- 01Chlorhexidine is the gold standard for plaque control, but it is associated with side effects on prolonged use. [Rawal A (2026)]
- 02Quercetin, a natural flavonoid with antioxidant and anti-inflammatory properties, has shown promise in vitro, but clinical evidence remains limited. [Rawal A (2026)]
- 03Conclusion Quercetin mouthwash demonstrated efficacy alternative to chlorhexidine in reducing gingival inflammation and controlling plaque within the limits of this exploratory trial, without associated side effects, making it a promising natural alternative for long-term use. [Rawal A (2026)]
- 04Background Gingivitis, a reversible inflammatory condition of the gingiva, is primarily caused by plaque accumulation. [Rawal A (2026)]
The current Migaku evidence database contains 2 reusable source documents for Quercetin Immune Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Chlorhexidine is the gold standard for plaque control, but it is associated with side effects on prolonged use. [Rawal A (2026); evidence level 2]
- Quercetin, a natural flavonoid with antioxidant and anti-inflammatory properties, has shown promise in vitro, but clinical evidence remains limited. [Rawal A (2026); evidence level 2]
- Conclusion Quercetin mouthwash demonstrated efficacy alternative to chlorhexidine in reducing gingival inflammation and controlling plaque within the limits of this exploratory trial, without associated side effects, making it a promising natural alternative for long-term use. [Rawal A (2026); evidence level 2]
- Background Gingivitis, a reversible inflammatory condition of the gingiva, is primarily caused by plaque accumulation. [Rawal A (2026); evidence level 2]
- 1 Infection during pregnancy severely threatens the health of both the mother and fetus during the perinatal period, and acts as a high-risk pathogenic factor for multiple pregnancy-related diseases. [Shi Jiena (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources